95 related articles for article (PubMed ID: 30496661)
1. Cannabidiolic Acid-Mediated Interference with AP-1 Transcriptional Activity in MDA-MB-231 Breast Cancer Cells.
Suzuki M; Takeda S; Okazaki H; Watanabe K; Takiguchi M; Aramaki H
Nat Prod Commun; 2017 May; 12(5):759-761. PubMed ID: 30496661
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness.
Takeda S; Himeno T; Kakizoe K; Okazaki H; Okada T; Watanabe K; Aramaki H
J Nat Med; 2017 Jan; 71(1):286-291. PubMed ID: 27530354
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiolic acid dampens the expression of cyclooxygenase-2 in MDA-MB-231 breast cancer cells: Possible implication of the peroxisome proliferator-activated receptor β/δ abrogation.
Hirao-Suzuki M; Takeda S; Koga T; Takiguchi M; Toda A
J Toxicol Sci; 2020; 45(4):227-236. PubMed ID: 32238697
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells.
Takeda S; Okazaki H; Ikeda E; Abe S; Yoshioka Y; Watanabe K; Aramaki H
J Toxicol Sci; 2014; 39(5):711-6. PubMed ID: 25242400
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis.
Takeda S; Misawa K; Yamamoto I; Watanabe K
Drug Metab Dispos; 2008 Sep; 36(9):1917-21. PubMed ID: 18556441
[TBL] [Abstract][Full Text] [Related]
6. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.
Takeda S; Okajima S; Miyoshi H; Yoshida K; Okamoto Y; Okada T; Amamoto T; Watanabe K; Omiecinski CJ; Aramaki H
Toxicol Lett; 2012 Nov; 214(3):314-9. PubMed ID: 22963825
[TBL] [Abstract][Full Text] [Related]
8. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells.
Detry C; Lamour V; Castronovo V; Bellahcène A
Bone; 2008 Feb; 42(2):422-31. PubMed ID: 18088579
[TBL] [Abstract][Full Text] [Related]
9. Chrysin inhibits tumor promoter-induced MMP-9 expression by blocking AP-1 via suppression of ERK and JNK pathways in gastric cancer cells.
Xia Y; Lian S; Khoi PN; Yoon HJ; Joo YE; Chay KO; Kim KK; Do Jung Y
PLoS One; 2015; 10(4):e0124007. PubMed ID: 25875631
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of proliferation of estrogen receptor‑positive MCF‑7 human breast cancer cells by tamoxifen through c‑Jun transcription factors.
Xu Y; Zou ST; Zhu R; Li W; Gu CW; Wei SH; Xie JM; Wu HR
Mol Med Rep; 2013 Apr; 7(4):1283-7. PubMed ID: 23404426
[TBL] [Abstract][Full Text] [Related]
11. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells.
Yu W; Simmons-Menchaca M; You H; Brown P; Birrer MJ; Sanders BG; Kline K
Mol Carcinog; 1998 Aug; 22(4):247-57. PubMed ID: 9726817
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
[TBL] [Abstract][Full Text] [Related]
13. Regulation of polyamine analogue cytotoxicity by c-Jun in human MDA-MB-435 cancer cells.
Huang Y; Keen JC; Hager E; Smith R; Hacker A; Frydman B; Valasinas AL; Reddy VK; Marton LJ; Casero RA; Davidson NE
Mol Cancer Res; 2004 Feb; 2(2):81-8. PubMed ID: 14985464
[TBL] [Abstract][Full Text] [Related]
14. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
Agadir A; Shealy YF; Hill DL; Zhang X
Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011
[TBL] [Abstract][Full Text] [Related]
15. Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1).
Endres M; Kneitz S; Orth MF; Perera RK; Zernecke A; Butt E
Oncotarget; 2016 Sep; 7(39):64244-64259. PubMed ID: 27588391
[TBL] [Abstract][Full Text] [Related]
16. Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen.
Altundag K; Altundag O; Gunduz M; Arun B
Med Hypotheses; 2004; 63(5):823-6. PubMed ID: 15488654
[TBL] [Abstract][Full Text] [Related]
17. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
[TBL] [Abstract][Full Text] [Related]
18. BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1.
Du J; Yang S; An D; Hu F; Yuan W; Zhai C; Zhu T
Cell Res; 2009 Apr; 19(4):487-96. PubMed ID: 19308091
[TBL] [Abstract][Full Text] [Related]
19. δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
Hu F; Wang C; Guo S; Sun W; Mi D; Gao Y; Zhang J; Zhu T; Yang S
Biochim Biophys Acta; 2011 Mar; 1809(3):200-10. PubMed ID: 21241837
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells.
Freund A; Jolivel V; Durand S; Kersual N; Chalbos D; Chavey C; Vignon F; Lazennec G
Oncogene; 2004 Aug; 23(36):6105-14. PubMed ID: 15208657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
